Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on May 21, 2008
J Am Soc Nephrol 19: 2020-2026, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007111174

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007111174v1
19/10/2020    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Bestard, O.
Right arrow Articles by Grinyó, J. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bestard, O.
Right arrow Articles by Grinyó, J. M.

CLINICAL RESEARCH

Presence of FoxP3+ Regulatory T Cells Predicts Outcome of Subclinical Rejection of Renal Allografts

Oriol Bestard*, Josep M. Cruzado*, Inés Rama*, Joan Torras*, Montse Gomà{dagger}, Daniel Serón*, Francesc Moreso*, Salvador Gil-Vernet* and Josep M. Grinyó*

Departments of * Nephrology and {dagger} Pathology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain

Correspondence: Dr. Oriol Bestard, Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain. Phone: 0034932607614; Fax: 0034932607603; E-mail: 35830obm{at}comb.es

Received for publication November 7, 2007. Accepted for publication February 22, 2008.

Subclinical rejection (SCR) of renal allografts refers to histologic patterns of acute rejection despite stable renal function. The clinical approach to SCR is controversial; it would be helpful to identify biomarkers that could determine whether the identified cellular infiltrates were detrimental. For investigation of whether the presence of FoxP3+ regulatory T cells (Treg) could help determine the functional importance of tubulointerstitial infiltrates observed in 6-mo protocol biopsies, 37 cases of SCR were evaluated. The presence of FoxP3+ Treg discriminated harmless from injurious infiltrates, evidenced by independently predicting better graft function 2 and 3 yr after transplantation. Furthermore, the FoxP3+ Treg/CD3+ T cell ratio positively correlated with graft function at 2 yr after transplantation, suggesting that an increasing proportion of Treg within the global T cell infiltrate may facilitate renal engraftment; therefore, immunostaining for FoxP3+ Treg in patients with SCR on protocol biopsies may ultimately be useful to identify patients who may require alterations in their immunosuppressive regimens.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. K. Chauhan, D. R. Saban, H. K. Lee, and R. Dana
Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation
J. Immunol., January 1, 2009; 182(1): 148 - 153.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP